cp wire

CP Wire Articles

Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive


Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today announced positive topline results for RGH-MD-53, a Phase 3 study of cariprazine for the... read more

Tue, 04/3/18 - 09:08 am
Citizen Petition Watch - Increased Activity Around Ditropan XL

There have been two citizen petitions (from two different companies) in the last two working days requesting that the FDA determine that Ditropan XL was not withdrawn from the market for reasons... read more

Mon, 04/2/18 - 05:25 pm
Healthcare on the Hill - Update - H.R.5298 a bill that would classify all opioid mu receptor agonists schedule I

The text of H.R. 5298 is now available. When we first saw the full title of this bill it appeared that it would, if passed, result in all opioids that act at mu receptor agonists being classified... read more

Mon, 04/2/18 - 02:40 pm
Radius Health Initiates Phase III Trial of Osteoporosis Injection Drug for Males

Radius Health, Inc. (Nasdaq:RDUS) announced Friday (3/30/2018) that the company has initiated the Phase 3 ATOM (Abaloparatide Treatment for Osteoporosis in Males) study of abaloparatide injection... read more

Mon, 04/2/18 - 09:53 am
Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise

Prior to today's announcement, Alkermes management appeared confident in the data supporting the approval of ALKS 5461. Alkermes had planned for the company to grow its salesforce by as much as 70... read more

Mon, 04/2/18 - 09:33 am

Pages